Sanofi halts trials of IL-6 drug for Covid-19, India to continue with trial of another drug of similar class

The decision casts a shadow on other similar classes of drugs such as Tocilizumab by Swiss drug maker Roche pharma, that are under trial for treating Covid-19 in countries including India. However, the investigator leading the Tocilizumab trial in India told ET that the efficacy of these drugs on moderate Covid-19 patients still needs to be studied.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news